Skip to main content

Table 1 Clinical baseline characteristics

From: Evaluation of three scoring systems for predicting renal prognosis in antineutrophil cytoplasmic antibody-associated glomerulonephritis

Characteristics

Total (n = 94)

Age (year)

60.0 (49.0, 67.0)

Female, n (%)

48.0 (51.1)

PR3-ANCA, n (%)

12.0 (12.8)

MPO-ANCA, n (%)

82.0 (87.2)

eGFR (ml/min/1.73 m2)

17.5 (9.3, 40.1)

Urinary protein (g/d)

1.8 (1.0, 2.7)

Urinary red blood cells (cells/μl)

148.5 (54.0, 286.8)

Normal glomeruli (%)

32.5 (12.8, 59.7)

TA/IF (> 25%), n (%)

17.0 (18.1)

RRS

3.0 (0, 7.0)

BVAS

18.0 (15.0, 21.0)

RVLs score

1.0 (1.0, 2.0)

  1. Data are displayed as the median (interquartile range), or number (percentage)
  2. PR3-ANCA Proteinase 3- antineutrophil cytoplasmic antibody, MPO-ANCA Myeloperoxidase-ANCA, eGFR estimated glomerular filtration rate, TA/IF renal tubular atrophy and interstitial fibrosis, RRS renal risk score, BVAS birmingham vasculitis activity score, RVLs renal vascular lesions